Last Name | Name | Awards | Contact | |
---|---|---|---|---|
Schreier | Hans Schreier | 1 |
Phase 1 SBIR
This project is designed to test the feasibility of targeted therapy for adult T-cell leukemia (ATL) using a novel CD4 receptor-selective delivery system based on "viralmimicry": artificial viral envelopes containing recombinant gp160, or covalently coupled recombinant gp120, of the human immunodeficiency virus (HIV). ATL is aggressive, resista...